Neoadjuvant Pembrolizumab for Lung Cancer | NEJM
45
0
2023-12-18 17:09
Aspirationally Resectable Neoadjuvant Tx Evolves in NSCLC
(EP.1) 3rd Chest-onco Education 2021 #ChestTU #SPN #NSCLC #lungcancer #chestCT
骶髂关节后路螺丝钉内固定
Iatrogenic Splenic Injury in Colorectal Surgery - Laparoscopic Hemostatic Control
肝门胆管癌切除术（86例切除经验 1983-1993）
骨关节炎
好好的告个别吧~
Colorectal Cancer Awareness Month - Mandi & Lea Ann’s Story
0 bullet chats
Please Sign In first
LikesSend-PenFavorites
Scan by WeChatUnauthorized reproduction is prohibited
Adjuvant pembrolizumab can improve disease-free survival among patients
with early-stage non–small-cell lung cancer. The effects of neoadjuvant
pembrolizumab in these patients are unclear.
New research findings are
summarized in this short video.
To see the full article, follow this link: https://nej.md/3WK7LMs
Comments 0
Please to post a comment~
Loading...
Related Suggestion